GOCO vs GS: Which Stock is Better?
Side-by-side comparison of GoHealth Inc. and Goldman Sachs Group Inc in 2026
GOCO
GoHealth Inc.
$2.28
GS
Goldman Sachs Group Inc
$943.37
Key Metrics Comparison
| Metric | GOCO | GS | Winner |
|---|---|---|---|
| Market Cap | $71.50M | $285.58B | GS |
| P/E Ratio | N/A | 18.40 | GS |
| EPS (TTM) | $N/A | $51.27 | GS |
| Revenue Growth | -0.7% | 0.2% | GS |
| Gross Margin | 80.5% | 82.9% | GS |
Analyze GOCO
Full quant analysis
Analyze GS
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GOCO or GS a better investment?
Comparing GOCO and GS: GoHealth Inc. has a market cap of $71.50M while Goldman Sachs Group Inc has $285.58B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GOCO and GS?
GOCO (GoHealth Inc.) and GS (Goldman Sachs Group Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GOCO or GS?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GOCO or GS?
GS has higher revenue growth at 0.2% vs -0.7% for GOCO.
Which company is more profitable: GOCO or GS?
Goldman Sachs Group Inc (GS) has higher gross margins at 82.9% compared to 80.5% for GOCO.
Which is the larger company: GOCO or GS?
Goldman Sachs Group Inc (GS) is larger with a market cap of $285.58B compared to $71.50M for GOCO.
Should I buy GOCO or GS in 2026?
Both GOCO and GS have investment merit. GOCO trades at $2.28 while GS trades at $943.37. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GOCO and GS stock?
Key differences: Market Cap ($71.50M vs $285.58B), P/E Ratio (N/A vs 18.4x), Revenue Growth (-0.7% vs 0.2%), Gross Margin (80.5% vs 82.9%).